Condition
Hypertension, Pulmonary clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Hypertension, Pulmonary clinical trials that are recruiting, at sites in 18 countries (most in China (2), Poland (2), South Korea (2)). By phase: Phase 3 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 18Countries
Newest Hypertension, Pulmonary clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Vasoactive Agents in Pulmonary Hypertension Crisis | — | Beijing, Beijing Municipality and 2 other locations | Recruiting | Jun 25, 2026 |
| TX000045 for pulmonary hypertension from interstitial lung disease | Phase 2 | Phoenix, Arizona and 15 other locations | Recruiting | Mar 16, 2026 |
| Digital stethoscope and 3-lead ECG detection of pulmonary hypertension and low ejection fraction | — | O'Fallon, Illinois and 3 other locations | Recruiting | Jul 28, 2025 |
| Deep-learning ECG to detect pulmonary hypertension | — | Taipei | Recruiting | Jul 23, 2025 |
| How lung capillary surface area changes after balloon pulmonary angioplasty for CTEPH | — | Montreal, Quebec | Recruiting | Feb 9, 2023 |
| Access to treatment for patients with pulmonary hypertension after completing a parent study | Phase 3 | Minsk and 44 other locations | Recruiting | Jan 5, 2022 |
All recruiting trials (6)
-
Vasoactive Agents in Pulmonary Hypertension Crisis
This trial tests whether dopamine, norepinephrine, or epinephrine can safely and effectively help people with a pulmonary hypertension crisis who are in the hospital.
-
TX000045 for pulmonary hypertension from interstitial lung disease
This study tests TX000045 to see if it can reduce pulmonary vascular resistance in people with PH caused by interstitial lung disease and to check its safety.
-
Digital stethoscope and 3-lead ECG detection of pulmonary hypertension and low ejection fraction
This project will test whether heart sounds and a three-lead ECG recorded with a digital stethoscope can find pulmonary hypertension or low left ventricular ejection fraction in adults having an echocardiogram.
-
Deep-learning ECG to detect pulmonary hypertension
This trial tests whether an AI-powered ECG can spot high blood pressure in the lungs (pulmonary hypertension) in adults aged 50–85 who have had a recent ECG.
-
How lung capillary surface area changes after balloon pulmonary angioplasty for CTEPH
This will test whether balloon pulmonary angioplasty restores downstream functional pulmonary capillary surface area in people with chronic thromboembolic pulmonary hypertension.
-
Access to treatment for patients with pulmonary hypertension after completing a parent study
This study is testing whether patients with pulmonary hypertension can keep receiving effective treatments after finishing a previous study to see if it remains safe for them.
Related topics
Quick answers
How many Hypertension, Pulmonary clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 18 countries. The most sites are in China (2 trials), Poland (2 trials), South Korea (2 trials), Taiwan (2 trials), United States (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.